🇺🇸 FDA
Pipeline program

TQF3250 placebo

TQF3250-Ia-01

Phase 1 small_molecule active

Quick answer

TQF3250 placebo for Hyperglycemia is a Phase 1 program (small_molecule) at Chia Tai Tianqing Pharmaceutical Group Co., with 1 ClinicalTrials.gov record(s).

Program details

Company
Chia Tai Tianqing Pharmaceutical Group Co.,
Indication
Hyperglycemia
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials